PSICOFARMACOLOGIA INFANTIL NO ESPECTRO DO AUTISMO E SUA ATUAÇÃO PARA A MELHORIA DA QUALIDADE DE VIDA E SUA SOCIALIBILIDADE
DOI:
https://doi.org/10.61164/rmnm.v12i3.3268Keywords:
psicofarmacologia; autismo; medicamentos; TEA; infantil.Abstract
It is extremely important to investigate and understand the use of medications to treat autism symptoms in children, with the aim of improving their quality of life. Furthermore, it is essential to personalize therapeutic approaches, offering safer and more appropriate treatments for each child, taking into account their specific needs and individual characteristics. This involves combining scientific and clinical approaches to investigate the use of medications in the treatment of children with autism, analyzing the effects of available pharmacological treatments, their efficacy, safety and impact on the development of children with autism. Child psychopharmacology in the autistic spectrum has shown advances in the treatment of behavioral symptoms, but there are still significant gaps, especially regarding the treatment of social and communication difficulties. It is essential that the use of medications is carefully monitored and personalized, with the aim of improving the quality of life of children.
Downloads
References
Ahrens AP, Hyötyläinen T, Petrone JR, Igelström K, George CD, Garrett TJ, Orešič M, Triplett EW, Ludvigsson J. Infant microbes and metabolites point to childhood neurodevelopmental disorders. Cell. 2024 Apr 11;187(8):1853-1873.e15. doi: 10.1016/j.cell.2024.02.035. Epub 2024 Apr 3. PMID: 38574728. DOI: https://doi.org/10.1016/j.cell.2024.02.035
Aishworiya R, Valica T, Hagerman R, Restrepo B. An Update on Psychopharmacological Treatment of Autism Spectrum Disorder. Neurotherapeutics. 2022 Jan;19(1):248-262. doi: 10.1007/s13311-022-01183-1. Epub 2022 Jan 14. PMID: 35029811; PMCID: PMC9130393. DOI: https://doi.org/10.1007/s13311-022-01183-1
Autism spectrum disorder in under 19s: support and management. London: National Institute for Health and Care Excellence (NICE); 2021 Jun 14. PMID: 34283415.
BARROS NETO, Sebastião Gonçalves de; BRUNONI, Decio; CYSNEIROS, Roberta Monterazzo. Abordagem psicofarmacológica no transtorno do espectro autista: uma revisão narrativa. Cad. Pós-Grad. Distúrb. Desenvolv., São Paulo , v. 19, n. 2, p. 38-60, dez. 2019 . Disponível em <http://pepsic.bvsalud.org/scielo.php?script=sci_arttext&pid=S151903072019000200004&lng=pt&nrm=iso>. acessos em 06 nov. 2024. https://doi.org/10.5935/cadernosdisturbios.v19n2p38-60. DOI: https://doi.org/10.5935/cadernosdisturbios.v19n2p38-60
Famitafreshi H, Karimian M. Overview of the Recent Advances in Pathophysiology and Treatment for Autism. CNS Neurol Disord Drug Targets. 2018;17(8):590-594. doi: 10.2174/1871527317666180706141654.PMID: 29984672. DOI: https://doi.org/10.2174/1871527317666180706141654
Gu Z, Dawson G, Engelhard M. Sex differences in the age of childhood autism diagnosis and the impact of co-occurring conditions. Autism Res. 2023 Dec;16(12):2391-2402. doi: 10.1002/aur.3043. Epub 2023 Nov 1. PMID: 37909391; DOI: https://doi.org/10.1002/aur.3043
PMCID: PMC10872618.
Khan KM, Jialal I. Folic Acid Deficiency. 2023 Jun 26. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 30570998
Lalanne S, Fougerou-Leurent C, Anderson GM, Schroder CM, Nir T, Chokron S, Delorme R, Claustrat B, Bellissant E, Kermarrec S, Franco P, Denis L, Tordjman S. Melatonin: From Pharmacokinetics to Clinical Use in Autism Spectrum Disorder. Int J Mol Sci. 2021 Feb 2;22(3):1490. doi: 10.3390/ijms22031490. PMID: 33540815; PMCID: PMC7867370. DOI: https://doi.org/10.3390/ijms22031490
LOPES, Ana Maria Costa da Silva. O autismo e suas conexões: qual medicação para o autista?. Psicol. rev. (Belo Horizonte), Belo Horizonte , v. 25, n. 3, p. 1343-1352, dez. 2019 Disponível em DOI: https://doi.org/10.5752/P.1678-9563.2019v25n3p1343-1352
<http://pepsic.bvsalud.org/scielo.php?script=sci_arttext&pid=S1677-11682019000300026&lng=pt&nrm=iso>. doi.org/10.5752/P.1677-1168.2019v25n3p1343-1352.
Miller LE, Dai YG, Fein DA, Robins DL. Characteristics of toddlers with early
versus later diagnosis of autism spectrum disorder. Autism. 2021
Feb;25(2):416-428. doi: 10.1177/1362361320959507. Epub 2020 Sep 26. PMID: DOI: https://doi.org/10.1177/1362361320959507
; PMCID: PMC7870497.
Moon SJ, Hwang JS, Shin AL, Kim JY, Bae SM, Sheehy-Knight J, Kim JW.
Accuracy of the Childhood Autism Rating Scale: a systematic review and meta-analysis. Dev Med Child Neurol. 2019 Sep;61(9):1030-1038. doi: DOI: https://doi.org/10.1111/dmcn.14246
1111/dmcn.14246. Epub 2019 Apr 11. PMID: 30977125.
Yu Y, Huang J, Chen X, Fu J, Wang X, Pu L, Gu C, Cai C. Efficacy and Safety
of Diet Therapies in Children With Autism Spectrum Disorder: A Systematic
Literature Review and Meta-Analysis. Front Neurol. 2022 Mar 14;13:844117. doi: DOI: https://doi.org/10.3389/fneur.2022.885179
3389/fneur.2022.844117. PMID: 35359629; PMCID: PMC8963985.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Revista Multidisciplinar do Nordeste Mineiro
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors who publish in this journal agree to the following terms:
Authors retain copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Creative Commons Attribution License, which permits the sharing of the work with proper acknowledgment of authorship and initial publication in this journal;
Authors are authorized to enter into separate, additional agreements for the non-exclusive distribution of the version of the work published in this journal (e.g., posting in an institutional repository or publishing it as a book chapter), provided that authorship and initial publication in this journal are properly acknowledged, and that the work is adapted to the template of the respective repository;
Authors are permitted and encouraged to post and distribute their work online (e.g., in institutional repositories or on their personal websites) at any point before or during the editorial process, as this may lead to productive exchanges and increase the impact and citation of the published work (see The Effect of Open Access);
Authors are responsible for correctly providing their personal information, including name, keywords, abstracts, and other relevant data, thereby defining how they wish to be cited. The journal’s editorial board is not responsible for any errors or inconsistencies in these records.
PRIVACY POLICY
The names and email addresses provided to this journal will be used exclusively for the purposes of this publication and will not be made available for any other purpose or to third parties.
Note: All content of the work is the sole responsibility of the author and the advisor.
